GO:0005515 | protein binding | 1.34e-05 | 1.31e-01 | 1.244 | 13 | 198 | 4124 |
GO:0010467 | gene expression | 3.24e-05 | 3.17e-01 | 3.075 | 6 | 49 | 535 |
GO:0010388 | cullin deneddylation | 4.56e-05 | 4.45e-01 | 7.553 | 2 | 4 | 8 |
GO:0016032 | viral process | 1.52e-04 | 1.00e+00 | 3.133 | 5 | 30 | 428 |
GO:0008180 | COP9 signalosome | 4.44e-04 | 1.00e+00 | 5.968 | 2 | 6 | 24 |
GO:0005654 | nucleoplasm | 5.06e-04 | 1.00e+00 | 2.363 | 6 | 68 | 876 |
GO:0008380 | RNA splicing | 1.20e-03 | 1.00e+00 | 3.772 | 3 | 21 | 165 |
GO:0006430 | lysyl-tRNA aminoacylation | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0004824 | lysine-tRNA ligase activity | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 1.33e-03 | 1.00e+00 | 9.553 | 1 | 1 | 1 |
GO:0005634 | nucleus | 1.60e-03 | 1.00e+00 | 1.210 | 10 | 158 | 3246 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.09e-03 | 1.00e+00 | 4.853 | 2 | 8 | 52 |
GO:0051716 | cellular response to stimulus | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0003747 | translation release factor activity | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 2 | 2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly | 2.66e-03 | 1.00e+00 | 8.553 | 1 | 1 | 2 |
GO:0000778 | condensed nuclear chromosome kinetochore | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 2 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.99e-03 | 1.00e+00 | 7.968 | 1 | 1 | 3 |
GO:0016363 | nuclear matrix | 4.08e-03 | 1.00e+00 | 4.363 | 2 | 10 | 73 |
GO:0001649 | osteoblast differentiation | 4.19e-03 | 1.00e+00 | 4.344 | 2 | 5 | 74 |
GO:0032057 | negative regulation of translational initiation in response to stress | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0005851 | eukaryotic translation initiation factor 2B complex | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 2 | 4 |
GO:0016779 | nucleotidyltransferase activity | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.32e-03 | 1.00e+00 | 7.553 | 1 | 1 | 4 |
GO:0070934 | CRD-mediated mRNA stabilization | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 2 | 5 |
GO:0005672 | transcription factor TFIIA complex | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0060744 | mammary gland branching involved in thelarche | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 6.64e-03 | 1.00e+00 | 7.231 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 6 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 2 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 7 |
GO:0051382 | kinetochore assembly | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 2 | 7 |
GO:0042981 | regulation of apoptotic process | 9.36e-03 | 1.00e+00 | 3.746 | 2 | 4 | 112 |
GO:0007049 | cell cycle | 9.85e-03 | 1.00e+00 | 3.707 | 2 | 8 | 115 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 1 | 8 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.16e-02 | 1.00e+00 | 3.587 | 2 | 4 | 125 |
GO:0071354 | cellular response to interleukin-6 | 1.19e-02 | 1.00e+00 | 6.383 | 1 | 1 | 9 |
GO:0000398 | mRNA splicing, via spliceosome | 1.21e-02 | 1.00e+00 | 3.553 | 2 | 15 | 128 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0009416 | response to light stimulus | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 4 | 10 |
GO:0032465 | regulation of cytokinesis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 4 | 11 |
GO:0006479 | protein methylation | 1.46e-02 | 1.00e+00 | 6.094 | 1 | 2 | 11 |
GO:0017025 | TBP-class protein binding | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 1 | 12 |
GO:0000132 | establishment of mitotic spindle orientation | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 12 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 3 | 13 |
GO:0060749 | mammary gland alveolus development | 1.72e-02 | 1.00e+00 | 5.853 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0070064 | proline-rich region binding | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 3 | 14 |
GO:0016597 | amino acid binding | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 1 | 14 |
GO:0016575 | histone deacetylation | 1.85e-02 | 1.00e+00 | 5.746 | 1 | 2 | 14 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.87e-02 | 1.00e+00 | 3.222 | 2 | 18 | 161 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0014003 | oligodendrocyte development | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 15 |
GO:0005839 | proteasome core complex | 2.11e-02 | 1.00e+00 | 5.553 | 1 | 1 | 16 |
GO:0004298 | threonine-type endopeptidase activity | 2.24e-02 | 1.00e+00 | 5.466 | 1 | 1 | 17 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.37e-02 | 1.00e+00 | 5.383 | 1 | 3 | 18 |
GO:0005844 | polysome | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 2 | 19 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.50e-02 | 1.00e+00 | 5.305 | 1 | 1 | 19 |
GO:0034080 | CENP-A containing nucleosome assembly | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 20 |
GO:0005743 | mitochondrial inner membrane | 2.73e-02 | 1.00e+00 | 2.931 | 2 | 9 | 197 |
GO:0030331 | estrogen receptor binding | 2.89e-02 | 1.00e+00 | 5.094 | 1 | 2 | 22 |
GO:0001103 | RNA polymerase II repressing transcription factor binding | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 23 |
GO:0000049 | tRNA binding | 3.02e-02 | 1.00e+00 | 5.029 | 1 | 2 | 23 |
GO:0006370 | 7-methylguanosine mRNA capping | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 5 | 24 |
GO:0008033 | tRNA processing | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 4 | 27 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 3.79e-02 | 1.00e+00 | 4.695 | 1 | 6 | 29 |
GO:0009408 | response to heat | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 1 | 31 |
GO:0003723 | RNA binding | 4.14e-02 | 1.00e+00 | 2.605 | 2 | 22 | 247 |
GO:0000786 | nucleosome | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 4.44e-02 | 1.00e+00 | 4.466 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 4.56e-02 | 1.00e+00 | 4.424 | 1 | 5 | 35 |
GO:0043434 | response to peptide hormone | 4.69e-02 | 1.00e+00 | 4.383 | 1 | 1 | 36 |
GO:0046982 | protein heterodimerization activity | 4.70e-02 | 1.00e+00 | 2.503 | 2 | 11 | 265 |
GO:0003743 | translation initiation factor activity | 4.82e-02 | 1.00e+00 | 4.344 | 1 | 8 | 37 |
GO:0006396 | RNA processing | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 6 | 40 |
GO:0005739 | mitochondrion | 5.26e-02 | 1.00e+00 | 1.774 | 3 | 32 | 659 |
GO:0006521 | regulation of cellular amino acid metabolic process | 5.33e-02 | 1.00e+00 | 4.195 | 1 | 2 | 41 |
GO:0000775 | chromosome, centromeric region | 5.33e-02 | 1.00e+00 | 4.195 | 1 | 6 | 41 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 5.58e-02 | 1.00e+00 | 4.127 | 1 | 2 | 43 |
GO:0009749 | response to glucose | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 1 | 45 |
GO:0000502 | proteasome complex | 6.08e-02 | 1.00e+00 | 3.998 | 1 | 3 | 47 |
GO:0032481 | positive regulation of type I interferon production | 6.21e-02 | 1.00e+00 | 3.968 | 1 | 3 | 48 |
GO:0051301 | cell division | 6.33e-02 | 1.00e+00 | 3.938 | 1 | 2 | 49 |
GO:0000278 | mitotic cell cycle | 6.36e-02 | 1.00e+00 | 2.258 | 2 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 6.47e-02 | 1.00e+00 | 2.245 | 2 | 17 | 317 |
GO:0006334 | nucleosome assembly | 6.58e-02 | 1.00e+00 | 3.881 | 1 | 4 | 51 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.71e-02 | 1.00e+00 | 3.853 | 1 | 3 | 52 |
GO:0006289 | nucleotide-excision repair | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 6 | 53 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.83e-02 | 1.00e+00 | 3.825 | 1 | 3 | 53 |
GO:0005829 | cytosol | 7.21e-02 | 1.00e+00 | 1.072 | 5 | 88 | 1787 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.21e-02 | 1.00e+00 | 3.746 | 1 | 5 | 56 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 7.33e-02 | 1.00e+00 | 3.720 | 1 | 2 | 57 |
GO:0006366 | transcription from RNA polymerase II promoter | 7.36e-02 | 1.00e+00 | 2.139 | 2 | 23 | 341 |
GO:0042826 | histone deacetylase binding | 7.46e-02 | 1.00e+00 | 3.695 | 1 | 5 | 58 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.70e-02 | 1.00e+00 | 3.646 | 1 | 5 | 60 |
GO:0071013 | catalytic step 2 spliceosome | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 5 | 61 |
GO:0007010 | cytoskeleton organization | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 4 | 61 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 7.83e-02 | 1.00e+00 | 3.622 | 1 | 2 | 61 |
GO:0006415 | translational termination | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 2 | 63 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 8.32e-02 | 1.00e+00 | 3.531 | 1 | 7 | 65 |
GO:0044822 | poly(A) RNA binding | 8.42e-02 | 1.00e+00 | 1.496 | 3 | 45 | 799 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 8.57e-02 | 1.00e+00 | 3.487 | 1 | 5 | 67 |
GO:0008360 | regulation of cell shape | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 3 | 70 |
GO:0030308 | negative regulation of cell growth | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 3 | 70 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 8.93e-02 | 1.00e+00 | 3.424 | 1 | 2 | 70 |
GO:0015630 | microtubule cytoskeleton | 9.54e-02 | 1.00e+00 | 3.324 | 1 | 5 | 75 |
GO:0030529 | ribonucleoprotein complex | 1.04e-01 | 1.00e+00 | 3.195 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 5 | 84 |
GO:0005737 | cytoplasm | 1.09e-01 | 1.00e+00 | 0.775 | 6 | 127 | 2633 |
GO:0000209 | protein polyubiquitination | 1.16e-01 | 1.00e+00 | 3.029 | 1 | 6 | 92 |
GO:0016477 | cell migration | 1.21e-01 | 1.00e+00 | 2.968 | 1 | 3 | 96 |
GO:0006413 | translational initiation | 1.24e-01 | 1.00e+00 | 2.924 | 1 | 6 | 99 |
GO:0003677 | DNA binding | 1.25e-01 | 1.00e+00 | 1.251 | 3 | 52 | 947 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.31e-01 | 1.00e+00 | 2.839 | 1 | 5 | 105 |
GO:0006397 | mRNA processing | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 12 | 110 |
GO:0043547 | positive regulation of GTPase activity | 1.39e-01 | 1.00e+00 | 2.746 | 1 | 2 | 112 |
GO:0003924 | GTPase activity | 1.47e-01 | 1.00e+00 | 2.658 | 1 | 7 | 119 |
GO:0016607 | nuclear speck | 1.51e-01 | 1.00e+00 | 2.622 | 1 | 8 | 122 |
GO:0006184 | GTP catabolic process | 1.60e-01 | 1.00e+00 | 2.531 | 1 | 7 | 130 |
GO:0005759 | mitochondrial matrix | 1.70e-01 | 1.00e+00 | 2.434 | 1 | 7 | 139 |
GO:0044212 | transcription regulatory region DNA binding | 1.75e-01 | 1.00e+00 | 2.393 | 1 | 13 | 143 |
GO:0005622 | intracellular | 1.77e-01 | 1.00e+00 | 2.373 | 1 | 2 | 145 |
GO:0001701 | in utero embryonic development | 1.87e-01 | 1.00e+00 | 2.286 | 1 | 7 | 154 |
GO:0007165 | signal transduction | 1.97e-01 | 1.00e+00 | 1.282 | 2 | 24 | 618 |
GO:0016071 | mRNA metabolic process | 2.04e-01 | 1.00e+00 | 2.144 | 1 | 10 | 170 |
GO:0016020 | membrane | 2.11e-01 | 1.00e+00 | 0.901 | 3 | 56 | 1207 |
GO:0006412 | translation | 2.13e-01 | 1.00e+00 | 2.077 | 1 | 12 | 178 |
GO:0005730 | nucleolus | 2.15e-01 | 1.00e+00 | 0.889 | 3 | 74 | 1217 |
GO:0003713 | transcription coactivator activity | 2.19e-01 | 1.00e+00 | 2.029 | 1 | 21 | 184 |
GO:0016070 | RNA metabolic process | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 188 |
GO:0005525 | GTP binding | 2.33e-01 | 1.00e+00 | 1.931 | 1 | 12 | 197 |
GO:0006281 | DNA repair | 2.39e-01 | 1.00e+00 | 1.888 | 1 | 24 | 203 |
GO:0008134 | transcription factor binding | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 10 | 209 |
GO:0043234 | protein complex | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 13 | 210 |
GO:0019899 | enzyme binding | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 7 | 210 |
GO:0005813 | centrosome | 2.53e-01 | 1.00e+00 | 1.791 | 1 | 10 | 217 |
GO:0030054 | cell junction | 2.54e-01 | 1.00e+00 | 1.785 | 1 | 5 | 218 |
GO:0003682 | chromatin binding | 2.88e-01 | 1.00e+00 | 1.576 | 1 | 15 | 252 |
GO:0008285 | negative regulation of cell proliferation | 3.12e-01 | 1.00e+00 | 1.439 | 1 | 11 | 277 |
GO:0009986 | cell surface | 3.25e-01 | 1.00e+00 | 1.368 | 1 | 5 | 291 |
GO:0005524 | ATP binding | 3.36e-01 | 1.00e+00 | 0.752 | 2 | 37 | 892 |
GO:0043066 | negative regulation of apoptotic process | 3.53e-01 | 1.00e+00 | 1.222 | 1 | 8 | 322 |
GO:0070062 | extracellular vesicular exosome | 3.77e-01 | 1.00e+00 | 0.458 | 3 | 51 | 1641 |
GO:0044267 | cellular protein metabolic process | 3.80e-01 | 1.00e+00 | 1.094 | 1 | 14 | 352 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.01e-01 | 1.00e+00 | 0.995 | 1 | 21 | 377 |
GO:0006915 | apoptotic process | 4.28e-01 | 1.00e+00 | 0.870 | 1 | 15 | 411 |
GO:0042803 | protein homodimerization activity | 4.42e-01 | 1.00e+00 | 0.811 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 4.60e-01 | 1.00e+00 | 0.733 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.63e-01 | 1.00e+00 | 0.720 | 1 | 29 | 456 |
GO:0005887 | integral component of plasma membrane | 5.46e-01 | 1.00e+00 | 0.386 | 1 | 8 | 575 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.88e-01 | 1.00e+00 | 0.222 | 1 | 29 | 644 |
GO:0005576 | extracellular region | 5.99e-01 | 1.00e+00 | 0.180 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 6.28e-01 | 1.00e+00 | 0.071 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 6.91e-01 | 1.00e+00 | -0.168 | 1 | 35 | 844 |
GO:0046872 | metal ion binding | 7.30e-01 | 1.00e+00 | -0.314 | 1 | 24 | 934 |
GO:0006351 | transcription, DNA-templated | 7.81e-01 | 1.00e+00 | -0.518 | 1 | 47 | 1076 |
GO:0005886 | plasma membrane | 9.28e-01 | 1.00e+00 | -1.248 | 1 | 46 | 1784 |